Chemical name: 2,2′-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropanenitrile)
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid
ARIMIDEX 1mg – PARA PHARMA
Arimidex 1 is a medication commonly used in the treatment of breast cancer. It is classified as a non-steroidal aromatase inhibitor, which means that it works by blocking the production of estrogen in the body. The active half-life of Arimidex 1 is approximately 2 days, meaning that the medication stays active in the body for a short period of time after it has been taken.
The dosage of Arimidex 1 typically ranges from 0.5 to 1 mg per day, depending on the individual patient’s needs and medical condition. Unlike some other medications used in breast cancer treatment, Arimidex 1 is not known to cause acne or water retention. It is also not associated with hepatotoxicity, or liver damage. Arimidex 1 does not cause HBR, or hot flashes, breast tenderness, and mood swings.
The active substance in Arimidex 1 is anastrozole, which is a potent aromatase inhibitor that works by blocking the production of estrogen in the body. By blocking estrogen production, Arimidex 1 helps to slow or stop the growth and spread of breast cancer cells in postmenopausal women.
Arimidex 1 is available in the form of 50 pills x 1 mg and is manufactured by Para Pharma, a reputable pharmaceutical company. In conclusion, Arimidex 1 is a highly effective medication that is widely used in the treatment of breast cancer in postmenopausal women. It is associated with few side effects and is considered a safe and effective option for most patients.